http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102210092-B1

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-312
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q17-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q11-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-135
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-99
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q17-00
filingDate 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber KR-102210092-B1
titleOfInvention Lactobacillus reuteri MG505 having anticariogenic activities and composition comprising the same
abstract The present invention is an antibacterial composition for inhibiting caries or periodontitis including Lactobacillus salivarius and Lactobacillus luteri derived from human body and various fermented foods, dental caries or periodontal disease prevention, treatment, pharmaceutical composition for improvement, health functional food composition and quasi-drugs It relates to the composition. The Lactobacillus luteri MG505 strain of the present invention has excellent inhibitory activity of Streptococcus mutans or Porilomonas gingivalins, and is suitable for probiotics because of its excellent acid resistance, bile resistance and self-aggregation ability, so it is a pharmaceutical for preventing, treating or improving tooth decay. , Food, quasi-drugs, etc. can be used in various ways.
priorityDate 2019-07-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453197090
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157561
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415966290
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID221067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439520
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415856284

Total number of triples: 30.